Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 300
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
Malar J ; 20(1): 37, 2021 Jan 11.
Artículo en Inglés | MEDLINE | ID: mdl-33430886

RESUMEN

BACKGROUND: Plasmodium falciparum, the parasite causing malaria, affects populations in many endemic countries threatening mainly individuals with low malaria immunity, especially children. Despite the approval of the first malaria vaccine Mosquirix™ and very promising data using cryopreserved P. falciparum sporozoites (PfSPZ), further research is needed to elucidate the mechanisms of humoral immunity for the development of next-generation vaccines and alternative malaria therapies including antibody therapy. A high prevalence of antibodies against AMA1 in immune individuals has made this antigen one of the major blood-stage vaccine candidates. MATERIAL AND METHODS: Using antibody phage display, an AMA1-specific growth inhibitory human monoclonal antibody from a malaria-immune Fab library using a set of three AMA1 diversity covering variants (DiCo 1-3), which represents a wide range of AMA1 antigen sequences, was selected. The functionality of the selected clone was tested in vitro using a growth inhibition assay with P. falciparum strain 3D7. To potentially improve affinity and functional activity of the isolated antibody, a phage display mediated light chain shuffling was employed. The parental light chain was replaced with a light chain repertoire derived from the same population of human V genes, these selected antibodies were tested in binding tests and in functionality assays. RESULTS: The selected parental antibody achieved a 50% effective concentration (EC50) of 1.25 mg/mL. The subsequent light chain shuffling led to the generation of four derivatives of the parental clone with higher expression levels, similar or increased affinity and improved EC50 against 3D7 of 0.29 mg/mL. Pairwise epitope mapping gave evidence for binding to AMA1 domain II without competing with RON2. CONCLUSION: We have thus shown that a compact immune human phage display library is sufficient for the isolation of potent inhibitory monoclonal antibodies and that minor sequence mutations dramatically increase expression levels in Nicotiana benthamiana. Interestingly, the antibody blocks parasite inhibition independently of binding to RON2, thus having a yet undescribed mode of action.


Asunto(s)
Anticuerpos Antiprotozoarios/inmunología , Antígenos de Protozoos/genética , Inmunidad Humoral , Proteínas de la Membrana/genética , Plasmodium falciparum/genética , Plasmodium falciparum/inmunología , Proteínas Protozoarias/genética , Anticuerpos Monoclonales/inmunología , Antígenos de Protozoos/metabolismo , Humanos , Vacunas contra la Malaria/química , Proteínas de la Membrana/metabolismo , Proteínas Protozoarias/metabolismo
2.
Int J Mol Sci ; 22(6)2021 Mar 16.
Artículo en Inglés | MEDLINE | ID: mdl-33809788

RESUMEN

Chitinases catalyze the degradation of chitin, a polymer of N-acetylglucosamine found in crustacean shells, insect cuticles, and fungal cell walls. There is great interest in the development of improved chitinases to address the environmental burden of chitin waste from the food processing industry as well as the potential medical, agricultural, and industrial uses of partially deacetylated chitin (chitosan) and its products (chito-oligosaccharides). The depolymerization of chitin can be achieved using chemical and physical treatments, but an enzymatic process would be more environmentally friendly and more sustainable. However, chitinases are slow-acting enzymes, limiting their biotechnological exploitation, although this can be overcome by molecular evolution approaches to enhance the features required for specific applications. The two main goals of this study were the development of a high-throughput screening system for chitinase activity (which could be extrapolated to other hydrolytic enzymes), and the deployment of this new method to select improved chitinase variants. We therefore cloned and expressed the Bacillus licheniformis DSM8785 chitinase A (chiA) gene in Escherichia coli BL21 (DE3) cells and generated a mutant library by error-prone PCR. We then developed a screening method based on fluorescence-activated cell sorting (FACS) using the model substrate 4-methylumbelliferyl ß-d-N,N',N″-triacetyl chitotrioside to identify improved enzymes. We prevented cross-talk between emulsion compartments caused by the hydrophobicity of 4-methylumbelliferone, the fluorescent product of the enzymatic reaction, by incorporating cyclodextrins into the aqueous phases. We also addressed the toxicity of long-term chiA expression in E. coli by limiting the reaction time. We identified 12 mutants containing 2-8 mutations per gene resulting in up to twofold higher activity than wild-type ChiA.


Asunto(s)
Quitinasas/genética , Evolución Molecular Dirigida , Citometría de Flujo , Ensayos Analíticos de Alto Rendimiento , Dominio Catalítico , Supervivencia Celular , Ciclodextrinas , Colorantes Fluorescentes/metabolismo , Biblioteca de Genes , Modelos Moleculares , Mutación/genética , Homología Estructural de Proteína , Especificidad por Sustrato , Trisacáridos , Umbeliferonas
3.
Biotechnol Bioeng ; 117(1): 17-29, 2020 01.
Artículo en Inglés | MEDLINE | ID: mdl-31520472

RESUMEN

Enzymes are biological catalysts with many industrial applications, but natural enzymes are usually unsuitable for industrial processes because they are not optimized for the process conditions. The properties of enzymes can be improved by directed evolution, which involves multiple rounds of mutagenesis and screening. By using mathematical models to predict the structure-activity relationship of an enzyme, and by defining the optimal combination of mutations in silico, we can significantly reduce the number of bench experiments needed, and hence the time and investment required to develop an optimized product. Here, we applied our innovative sequence-activity relationship methodology (innov'SAR) to improve glucose oxidase activity in the presence of different mediators across a range of pH values. Using this machine learning approach, a predictive model was developed and the optimal combination of mutations was determined, leading to a glucose oxidase mutant (P1) with greater specificity for the mediators ferrocene-methanol (12-fold) and nitrosoaniline (8-fold), compared to the wild-type enzyme, and better performance in three pH-adjusted buffers. The kcat /KM ratio of P1 increased by up to 121 folds compared to the wild type enzyme at pH 5.5 in the presence of ferrocene methanol.


Asunto(s)
Evolución Molecular Dirigida/métodos , Glucosa Oxidasa , Aprendizaje Automático , Mutagénesis Sitio-Dirigida/métodos , Mutación , Secuencia de Aminoácidos , Compuestos Ferrosos/metabolismo , Glucosa/metabolismo , Glucosa Oxidasa/química , Glucosa Oxidasa/genética , Glucosa Oxidasa/metabolismo , Concentración de Iones de Hidrógeno , Cinética , Modelos Estadísticos , Nitrosaminas/metabolismo
4.
Mol Divers ; 24(3): 593-601, 2020 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-31154590

RESUMEN

Cellobiose dehydrogenase (CDH, EC 1.1.99.18) from white rot fungi Phanerochaete chrysosporium can be used for constructing biosensors and biofuel cells, for bleaching cotton in textile industry, and recently, the enzyme has found an important application in biomedicine as an antimicrobial and antibiofilm agent. Stability and activity of the wild-type (wt) CDH and mutants at methionine residues in the presence of hydrogen peroxide were investigated. Saturation mutagenesis libraries were made at the only methionine in heme domain M65 and two methionines M685 and M738 in the flavin domain that were closest to the active site. After screening the libraries, three mutants with increased activity and stability in the presence of peroxide were found, M65F with 70% of residual activity after 6 h of incubation in 0.3 M hydrogen peroxide, M738S with 80% of residual activity and M685Y with over 90% of residual activity compared to wild-type CDH that retained 40% of original activity. Combined mutants showed no activity. The most stable mutant M685Y with 5.8 times increased half-life in the presence of peroxide showed also 2.5 times increased kcat for lactose compared to wtCDH and could be good candidate for applications in biofuel cells and biocatalysis for lactobionic acid production.


Asunto(s)
Deshidrogenasas de Carbohidratos/genética , Deshidrogenasas de Carbohidratos/metabolismo , Peróxidos/farmacología , Ingeniería de Proteínas , Deshidrogenasas de Carbohidratos/química , Estabilidad de Enzimas/efectos de los fármacos , Cinética , Modelos Moleculares , Mutación , Oxidación-Reducción , Phanerochaete/enzimología , Conformación Proteica
5.
Molecules ; 25(10)2020 May 22.
Artículo en Inglés | MEDLINE | ID: mdl-32455903

RESUMEN

Glucose oxidase (GOx) is an important industrial enzyme that can be optimized for specific applications by mutagenesis and activity-based screening. To increase the efficiency of this approach, we have developed a new ultrahigh-throughput screening platform based on a microfluidic lab-on-chip device that allows the sorting of GOx mutants from a saturation mutagenesis library expressed on the surface of yeast cells. GOx activity was measured by monitoring the fluorescence of water microdroplets dispersed in perfluorinated oil. The signal was generated via a series of coupled enzyme reactions leading to the formation of fluorescein. Using this new method, we were able to enrich the yeast cell population by more than 35-fold for GOx mutants with higher than wild-type activity after two rounds of sorting, almost double the efficiency of our previously described flow cytometry platform. We identified and characterized novel GOx mutants, the most promising of which (M6) contained a combination of six point mutations that increased the catalytic constant kcat by 2.1-fold compared to wild-type GOx and by 1.4-fold compared to a parental GOx variant. The new microfluidic platform for GOx was therefore more sensitive than flow cytometry and supports comprehensive screens of gene libraries containing multiple mutations per gene.


Asunto(s)
Glucosa Oxidasa/genética , Ensayos Analíticos de Alto Rendimiento , Proteínas Mutantes/genética , Saccharomyces cerevisiae/genética , Evolución Molecular Dirigida , Citometría de Flujo , Biblioteca de Genes , Glucosa Oxidasa/química , Glucosa Oxidasa/aislamiento & purificación , Dispositivos Laboratorio en un Chip , Mutagénesis/genética , Proteínas Mutantes/aislamiento & purificación , Conformación Proteica , Ingeniería de Proteínas , Saccharomyces cerevisiae/enzimología , Relación Estructura-Actividad
6.
Plant Biotechnol J ; 17(8): 1560-1566, 2019 08.
Artículo en Inglés | MEDLINE | ID: mdl-30672078

RESUMEN

Industrial plant biotechnology applications include the production of sustainable fuels, complex metabolites and recombinant proteins, but process development can be impaired by a lack of reliable and scalable screening methods. Here, we describe a rapid and versatile expression system which involves the infusion of Agrobacterium tumefaciens into three-dimensional, porous plant cell aggregates deprived of cultivation medium, which we have termed plant cell packs (PCPs). This approach is compatible with different plant species such as Nicotiana tabacum BY2, Nicotiana benthamiana or Daucus carota and 10-times more effective than transient expression in liquid plant cell culture. We found that the expression of several proteins was similar in PCPs and intact plants, for example, 47 and 55 mg/kg for antibody 2G12 expressed in BY2 PCPs and N. tabacum plants respectively. Additionally, the expression of specific enzymes can either increase the content of natural plant metabolites or be used to synthesize novel small molecules in the PCPs. The PCP method is currently scalable from a microtiter plate format suitable for high-throughput screening to 150-mL columns suitable for initial product preparation. It therefore combined the speed of transient expression in plants with the throughput of microbial screening systems. Plant cell packs therefore provide a convenient new platform for synthetic biology approaches, metabolic engineering and conventional recombinant protein expression techniques that require the multiplex analysis of several dozen up to hundreds of constructs for efficient product and process development.


Asunto(s)
Ingeniería Metabólica , Células Vegetales/metabolismo , Plantas Modificadas Genéticamente/metabolismo , Proteínas Recombinantes/biosíntesis , Agrobacterium tumefaciens , Daucus carota/metabolismo , Nicotiana/metabolismo
7.
Plant Biotechnol J ; 17(2): 350-361, 2019 02.
Artículo en Inglés | MEDLINE | ID: mdl-29969180

RESUMEN

Plants offer fast, flexible and easily scalable alternative platforms for the production of pharmaceutical proteins, but differences between plant and mammalian N-linked glycans, including the presence of ß-1,2-xylose and core α-1,3-fucose residues in plants, can affect the activity, potency and immunogenicity of plant-derived proteins. Nicotiana benthamiana is widely used for the transient expression of recombinant proteins so it is desirable to modify the endogenous N-glycosylation machinery to allow the synthesis of complex N-glycans lacking ß-1,2-xylose and core α-1,3-fucose. Here, we used multiplex CRISPR/Cas9 genome editing to generate N. benthamiana production lines deficient in plant-specific α-1,3-fucosyltransferase and ß-1,2-xylosyltransferase activity, reflecting the mutation of six different genes. We confirmed the functional gene knockouts by Sanger sequencing and mass spectrometry-based N-glycan analysis of endogenous proteins and the recombinant monoclonal antibody 2G12. Furthermore, we compared the CD64-binding affinity of 2G12 glycovariants produced in wild-type N. benthamiana, the newly generated FX-KO line, and Chinese hamster ovary (CHO) cells, confirming that the glyco-engineered antibody performed as well as its CHO-produced counterpart.


Asunto(s)
Anticuerpos Monoclonales/metabolismo , Nicotiana/enzimología , Proteínas de Plantas/metabolismo , Polisacáridos/metabolismo , Animales , Anticuerpos Monoclonales/inmunología , Anticuerpos ampliamente neutralizantes , Células CHO , Sistemas CRISPR-Cas , Cricetulus , Fucosa/metabolismo , Fucosiltransferasas/genética , Fucosiltransferasas/metabolismo , Edición Génica , Técnicas de Inactivación de Genes , Glicosilación , Anticuerpos Anti-VIH , Agricultura Molecular , Pentosiltransferasa/genética , Pentosiltransferasa/metabolismo , Proteínas de Plantas/genética , Plantas Modificadas Genéticamente , Proteínas Recombinantes , Nicotiana/genética , Xilosa/metabolismo , UDP Xilosa Proteína Xilosiltransferasa
8.
Protein Expr Purif ; 154: 25-32, 2019 02.
Artículo en Inglés | MEDLINE | ID: mdl-30237128

RESUMEN

Chitin is an abundant biopolymer found mainly in the exoskeleton of crustaceans and insects. The degradation of chitin using chitinases is one way to address the accumulation of chitin waste streams in the environment, and research has therefore focused on the identification, improvement and expression of suitable enzymes. Here we describe the production, purification and characterization of Bacillus licheniformis chitinase A in the Pichia pastoris expression system. Optimal enzyme activity occurred at pH 4.0-5.0 and within the temperature range 50-60 °C. With colloidal chitin as the substrate, the Km (2.307 mM) and Vmax (0.024 mM min-1) of the enzyme were determined using a 3,5-dinitrosalicylic acid assay. The degradation products of colloidal chitin and hexa-N-acetylchitohexaose were compared by thin-layer chromatography. The activity of the glycosylated enzyme produced in P. pastoris was compared with the in vitro deglycosylated and aglycosylated version produced in Escherichia coli. We showed that the glycosylated chitinase was more active than the deglycosylated and aglycosylated variants.


Asunto(s)
Bacillus licheniformis , Proteínas Bacterianas , Quitinasas , Bacillus licheniformis/enzimología , Bacillus licheniformis/genética , Proteínas Bacterianas/biosíntesis , Proteínas Bacterianas/química , Proteínas Bacterianas/genética , Proteínas Bacterianas/aislamiento & purificación , Quitinasas/biosíntesis , Quitinasas/química , Quitinasas/genética , Quitinasas/aislamiento & purificación , Estabilidad de Enzimas , Calor , Concentración de Iones de Hidrógeno , Pichia/enzimología , Pichia/genética , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/aislamiento & purificación
9.
Microb Cell Fact ; 18(1): 192, 2019 Nov 05.
Artículo en Inglés | MEDLINE | ID: mdl-31690314

RESUMEN

BACKGROUND: Terpenoids are of high interest as chemical building blocks and pharmaceuticals. In microbes, terpenoids can be synthesized via the methylerythritol phosphate (MEP) or mevalonate (MVA) pathways. Although the MEP pathway has a higher theoretical yield, metabolic engineering has met with little success because the regulation of the pathway is poorly understood. RESULTS: We applied metabolic control analysis to the MEP pathway in Escherichia coli expressing a heterologous isoprene synthase gene (ispS). The expression of ispS led to the accumulation of isopentenyl pyrophosphate (IPP)/dimethylallyl pyrophosphate (DMAPP) and severely impaired bacterial growth, but the coexpression of ispS and isopentenyl diphosphate isomerase (idi) restored normal growth and wild-type IPP/DMAPP levels. Targeted proteomics and metabolomics analysis provided a quantitative description of the pathway, which was perturbed by randomizing the ribosome binding site in the gene encoding 1-deoxyxylulose 5-phosphate synthase (Dxs). Dxs has a flux control coefficient of 0.35 (i.e., a 1% increase in Dxs activity resulted in a 0.35% increase in pathway flux) in the isoprene-producing strain and therefore exerted significant control over the flux though the MEP pathway. At higher dxs expression levels, the intracellular concentration of 2-C-methyl-D-erythritol-2,4-cyclopyrophosphate (MEcPP) increased substantially in contrast to the other MEP pathway intermediates, which were linearly dependent on the abundance of Dxs. This indicates that 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase (IspG), which consumes MEcPP, became saturated and therefore limited the flux towards isoprene. The higher intracellular concentrations of MEcPP led to the efflux of this intermediate into the growth medium. DISCUSSION: These findings show the importance of Dxs, Idi and IspG and metabolite export for metabolic engineering of the MEP pathway and will facilitate further approaches for the microbial production of valuable isoprenoids.


Asunto(s)
Eritritol/análogos & derivados , Escherichia coli , Ingeniería Metabólica/métodos , Fosfatos de Azúcar/metabolismo , Terpenos/metabolismo , Butadienos/metabolismo , Eritritol/metabolismo , Escherichia coli/genética , Escherichia coli/metabolismo , Hemiterpenos/metabolismo , Ácido Mevalónico/metabolismo
10.
Mar Drugs ; 17(8)2019 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-31374920

RESUMEN

Chitin is an abundant polysaccharide primarily produced as an industrial waste stream during the processing of crustaceans. Despite the limited applications of chitin, there is interest from the medical, agrochemical, food and cosmetic industries because it can be converted into chitosan and partially acetylated chitosan oligomers (COS). These molecules have various useful properties, including antimicrobial and anti-inflammatory activities. The chemical production of COS is environmentally hazardous and it is difficult to control the degree of polymerization and acetylation. These issues can be addressed by using specific enzymes, particularly chitinases, chitosanases and chitin deacetylases, which yield better-defined chitosan and COS mixtures. In this review, we summarize recent chemical and enzymatic approaches for the production of chitosan and COS. We also discuss a design-of-experiments approach for process optimization that could help to enhance enzymatic processes in terms of product yield and product characteristics. This may allow the production of novel COS structures with unique functional properties to further expand the applications of these diverse bioactive molecules.


Asunto(s)
Quitina/química , Quitosano/síntesis química , Crustáceos/química , Tecnología Química Verde/métodos , Amidohidrolasas/química , Animales , Quitinasas/química , Glicósido Hidrolasas/química , Residuos Industriales
11.
Int J Mol Sci ; 20(12)2019 Jun 13.
Artículo en Inglés | MEDLINE | ID: mdl-31200517

RESUMEN

The advent of precise genome-editing tools has revolutionized the way we create new plant varieties. Three groups of tools are now available, classified according to their mechanism of action: Programmable sequence-specific nucleases, base-editing enzymes, and oligonucleotides. The corresponding techniques not only lead to different outcomes, but also have implications for the public acceptance and regulatory approval of genome-edited plants. Despite the high efficiency and precision of the tools, there are still major bottlenecks in the generation of new and improved varieties, including the efficient delivery of the genome-editing reagents, the selection of desired events, and the regeneration of intact plants. In this review, we evaluate current delivery and regeneration methods, discuss their suitability for important crop species, and consider the practical aspects of applying the different genome-editing techniques in agriculture.


Asunto(s)
Edición Génica/métodos , Fitomejoramiento/métodos , Edición Génica/legislación & jurisprudencia , Edición Génica/normas , Fitomejoramiento/legislación & jurisprudencia , Fitomejoramiento/normas
12.
Protein Expr Purif ; 152: 122-130, 2018 12.
Artículo en Inglés | MEDLINE | ID: mdl-30059744

RESUMEN

Plants as a platform for recombinant protein expression are now economically comparable to well-established systems, such as microbes and mammalian cells, thanks to advantages such as scalability and product safety. However, downstream processing accounts for the majority of the final product costs because plant extracts contain large quantities of host cell proteins (HCPs) that must be removed using elaborate purification strategies. Heat precipitation in planta (blanching) can remove ∼80% of HCPs and thus simplify further purification steps, but this is only possible if the target protein is thermostable. Here we describe a combination of blanching and chromatography to purify the thermostable transmission-blocking malaria vaccine candidate FQS, which was transiently expressed in Nicotiana benthamiana leaves. If the blanching temperature exceeded a critical threshold of ∼75 °C, FQS was no longer recognized by the malaria transmission-blocking monoclonal antibody 4B7. A design-of-experiments approach revealed that reducing the blanching temperature from 80 °C to 70 °C restored antibody binding while still precipitating most HCPs. We also found that blanching inhibited the degradation of FQS in plant extracts, probably due to the thermal inactivation of proteases. We screened hydrophobic interaction chromatography materials using miniature columns and a liquid-handling station. Octyl Sepharose achieved the highest FQS purity during the primary capture step and led to a final purity of ∼72% with 60% recovery via step elution. We found that 30-75% FQS was lost during ultrafiltration/diafiltration, giving a final yield of 9 mg kg-1 plant material after purification based on an initial yield of ∼49 mg kg-1 biomass after blanching.


Asunto(s)
Anticuerpos Monoclonales/química , Anticuerpos Antiprotozoarios/química , Vacunas contra la Malaria/aislamiento & purificación , Nicotiana/genética , Proteínas de Plantas/aislamiento & purificación , Proteínas Protozoarias/aislamiento & purificación , Anticuerpos Monoclonales/metabolismo , Anticuerpos Antiprotozoarios/metabolismo , Cromatografía de Afinidad/métodos , Clonación Molecular , Análisis Factorial , Expresión Génica , Vectores Genéticos/química , Vectores Genéticos/metabolismo , Calor , Vacunas contra la Malaria/biosíntesis , Vacunas contra la Malaria/genética , Hojas de la Planta/genética , Hojas de la Planta/metabolismo , Proteínas de Plantas/química , Plantas Modificadas Genéticamente , Unión Proteica , Desnaturalización Proteica , Proteínas Protozoarias/biosíntesis , Proteínas Protozoarias/genética , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/genética , Proteínas Recombinantes/aislamiento & purificación , Sefarosa/análogos & derivados , Nicotiana/química , Nicotiana/metabolismo , Ultrafiltración/métodos
13.
Small ; 13(48)2017 12.
Artículo en Inglés | MEDLINE | ID: mdl-29125698

RESUMEN

Plant virus nanoparticles are often used to display functional amino acids or small peptides, thus serving as building blocks in application areas as diverse as nanoelectronics, bioimaging, vaccination, drug delivery, and bone differentiation. This is most easily achieved by expressing coat protein fusions, but the assembly of the corresponding virus particles can be hampered by factors such as the fusion protein size, amino acid composition, and post-translational modifications. Size constraints can be overcome by using the Foot and mouth disease virus 2A sequence, but the compositional limitations cannot be avoided without the introduction of time-consuming chemical modifications. SpyTag/SpyCatcher technology is used in the present study to covalently attach the Trichoderma reesei endoglucanase Cel12A to Potato virus X (PVX) nanoparticles. The formation of PVX particles is confirmed by western blot, and the ability of the particles to display Cel12A is demonstrated by enzyme-linked immunosorbent assays and transmission electron microscopy. Enzymatic assays show optimal reaction conditions of 50 °C and pH 6.5, and an increased substrate conversion rate compared to free enzymes. It is concluded that PVX displaying the SpyTag can serve as new scaffold for protein display, most notably for proteins with post-translational modifications.


Asunto(s)
Celulasa/metabolismo , Potexvirus/metabolismo , Ingeniería de Proteínas/métodos , Proteínas Virales/metabolismo , Virión/metabolismo , Cinética
14.
Cell Microbiol ; 18(4): 573-90, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26457721

RESUMEN

The acquisition of regulatory proteins is a means of blood-borne pathogens to avoid destruction by the human complement. We recently showed that the gametes of the human malaria parasite Plasmodium falciparum bind factor H (FH) from the blood meal of the mosquito vector to assure successful sexual reproduction, which takes places in the mosquito midgut. While these findings provided a first glimpse of a complex mechanism used by Plasmodium to control the host immune attack, it is hitherto not known, how the pathogenic blood stages of the malaria parasite evade destruction by the human complement. We now show that the human complement system represents a severe threat for the replicating blood stages, particularly for the reinvading merozoites, with complement factor C3b accumulating on the surfaces of the intraerythrocytic schizonts as well as of free merozoites. C3b accumulation initiates terminal complement complex formation, in consequence resulting in blood stage lysis. To inactivate C3b, the parasites bind FH as well as related proteins FHL-1 and CFHR-1 to their surface, and FH binding is trypsin-resistant. Schizonts acquire FH via two contact sites, which involve CCP modules 5 and 20. Blockage of FH-mediated protection via anti-FH antibodies results in significantly impaired blood stage replication, pointing to the plasmodial complement evasion machinery as a promising malaria vaccine target.


Asunto(s)
Factor H de Complemento/metabolismo , Proteínas del Sistema Complemento/metabolismo , Interacciones Huésped-Patógeno , Evasión Inmune , Plasmodium falciparum/inmunología , Plasmodium falciparum/metabolismo , Humanos , Unión Proteica
15.
Pharm Res ; 34(4): 696-703, 2017 04.
Artículo en Inglés | MEDLINE | ID: mdl-28074431

RESUMEN

PURPOSE: Targeted theranostics is an alternative strategy in cancer management that aims to improve cancer detection and treatment simultaneously. This approach combines potent therapeutic and diagnostic agents with the specificity of different cell receptor ligands in one product. The success of antibody drug conjugates (ADCs) in clinical practice has encouraged the development of antibody theranostics conjugates (ATCs). However, the generation of homogeneous and pharmaceutically-acceptable ATCs remains a major challenge. The aim of this study is to detect and eliminate ovarian cancer cells on-demand using an ATC directed to EGFR. METHODS: An ATC with a defined drug-to-antibody ratio was generated by the site-directed conjugation of IRDye®700 to a self-labeling protein (SNAP-tag) fused to an EGFR-specific antibody fragment (scFv-425). RESULTS: In vitro and ex vivo imaging showed that the ATC based on scFv-425 is suitable for the highly specific detection of EGFR+ ovarian cancer cell, human tissues and ascites samples. The construct was also able to eliminate EGFR+ cells and human ascites cells with IC50 values of 45-66 nM and 40-90 nM, respectively. CONCLUSION: Our experiments provide a framework to create a versatile technology platform for the development of ATCs for precise detection and treatment of ovarian cancer cells.


Asunto(s)
Apoptosis/efectos de los fármacos , Receptores ErbB/metabolismo , Inmunoconjugados/farmacología , Neoplasias Ováricas/diagnóstico por imagen , Neoplasias Ováricas/tratamiento farmacológico , Fotoquimioterapia , Anticuerpos Monoclonales/química , Línea Celular Tumoral , Femenino , Colorantes Fluorescentes/química , Humanos , Inmunoconjugados/química , Región Variable de Inmunoglobulina/química , Indoles/química , Concentración 50 Inhibidora , Compuestos de Organosilicio/química , Neoplasias Ováricas/metabolismo , Neoplasias Ováricas/patología , Anticuerpos de Cadena Única/química , Espectroscopía Infrarroja Corta/métodos , Nanomedicina Teranóstica
16.
Int J Cancer ; 139(4): 916-27, 2016 08 15.
Artículo en Inglés | MEDLINE | ID: mdl-27037627

RESUMEN

Chondroitin sulfate proteoglycan 4 (CSPG4) has been identified as a highly promising target antigen for immunotherapy of triple-negative breast cancer (TNBC). TNBC represents a highly aggressive heterogeneous group of tumors lacking expression of estrogen, progesterone and human epidermal growth factor receptor 2. TNBC is particularly prevalent among young premenopausal women. No suitable targeted therapies are currently available and therefore, novel agents for the targeted elimination of TNBC are urgently needed. Here, we present a novel cytolytic fusion protein (CFP), designated αCSPG4(scFv)-MAP, that consists of a high affinity CSPG4-specific single-chain antibody fragment (scFv) genetically fused to a functionally enhanced form of the human microtubule-associated protein (MAP) tau. Our data indicate that αCSPG4(scFv)-MAP efficiently targets CSPG4(+) TNBC-derived cell lines MDA-MB-231 and Hs 578T and potently inhibits their growth with IC50 values of ∼200 nM. Treatment with αCSPG(scFv)-MAP resulted in induction of the mitochondrial stress pathway by activation of caspase-9 as well as endonuclease G translocation to the nucleus, while induction of the caspase-3 apoptosis pathway was not detectable. Importantly, in vivo studies in mice bearing human breast cancer xenografts revealed efficient targeting to and accumulation of αCSPG4(scFv)-MAP at tumor sites resulting in prominent tumor regression. Taken together, this preclinical proof of concept study confirms the potential clinical value of αCSPG4(scFv)-MAP as a novel targeted approach for the elimination of CSPG4-positive TNBC.


Asunto(s)
Anticuerpos Monoclonales/genética , Proteoglicanos Tipo Condroitín Sulfato/metabolismo , Proteínas de la Membrana/metabolismo , Proteínas Recombinantes de Fusión/farmacología , Anticuerpos de Cadena Única/genética , Neoplasias de la Mama Triple Negativas/metabolismo , Proteínas tau/metabolismo , Animales , Biomarcadores , Biomarcadores de Tumor , Caspasa 3/metabolismo , Caspasa 9/metabolismo , Ciclo Celular/efectos de los fármacos , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Proteoglicanos Tipo Condroitín Sulfato/genética , Modelos Animales de Enfermedad , Femenino , Expresión Génica , Humanos , Proteínas de la Membrana/genética , Ratones , Terapia Molecular Dirigida , Unión Proteica , Transporte de Proteínas , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/aislamiento & purificación , Neoplasias de la Mama Triple Negativas/tratamiento farmacológico , Neoplasias de la Mama Triple Negativas/patología , Tubulina (Proteína)/metabolismo , Ensayos Antitumor por Modelo de Xenoinjerto , Proteínas tau/genética
17.
BMC Biotechnol ; 16: 18, 2016 Feb 17.
Artículo en Inglés | MEDLINE | ID: mdl-26883813

RESUMEN

BACKGROUND: In an earlier study we developed a unique strategy allowing us to specifically eliminate antigen-specific murine B cells via their distinct B cell receptors using a new class of fusion proteins. In the present work we elaborated our idea to demonstrate the feasibility of specifically addressing and eliminating human memory B cells. RESULTS: The present study reveals efficient adaptation of the general approach to selectively target and eradicate human memory B cells. In order to demonstrate the feasibility we engineered a fusion protein following the principle of recombinant immunotoxins by combining a model antigen (tetanus toxoid fragment C, TTC) for B cell receptor targeting and a truncated version of Pseudomonas aeruginosa exotoxin A (ETA') to induce apoptosis after cellular uptake. The TTC-ETA' fusion protein not only selectively bound to a TTC-reactive murine B cell hybridoma cell line in vitro but also to freshly isolated human memory B cells from immunized donors ex vivo. Specific toxicity was confirmed on an antigen-specific population of human CD27(+) memory B cells. CONCLUSIONS: This protein engineering strategy can be used as a generalized platform approach for the construction of therapeutic fusion proteins with disease-relevant antigens as B cell receptor-binding domains, offering a promising approach for the specific depletion of autoreactive B-lymphocytes in B cell-driven autoimmune diseases.


Asunto(s)
Modelos Inmunológicos , Receptores de Superficie Celular/metabolismo , Proteínas Recombinantes de Fusión/metabolismo , Toxoide Tetánico/metabolismo , Animales , Linfocitos B/química , Linfocitos B/metabolismo , Células Cultivadas , Escherichia coli , Células HEK293 , Humanos , Hibridomas/inmunología , Hibridomas/metabolismo , Leucocitos Mononucleares/metabolismo , Ratones , Receptores de Superficie Celular/química , Proteínas Recombinantes de Fusión/química , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/inmunología , Toxoide Tetánico/química , Toxoide Tetánico/genética , Toxoide Tetánico/inmunología
18.
Immunol Cell Biol ; 94(5): 470-8, 2016 05.
Artículo en Inglés | MEDLINE | ID: mdl-26743033

RESUMEN

Classical immunotoxins compromise a binding component (for example, a ligand, antibody or fragment thereof) and a cytotoxic component, usually derived from bacteria or plants (for example, Pseudomonas exotoxin A or ricin). Despite successful testing in vitro, the clinical development of immunotoxins has been hampered by immunogenicity and unsatisfactory safety profiles. Therefore, research has focused on fully human pro-apoptotic components suitable for the development of cytolytic fusion proteins (CFP). We recently reported that human microtubule-associated protein tau (MAP) can induce apoptosis when delivered to rapidly proliferating cancer cells. Here, we describe a new fully human CFP called H22(scFv)-MAP, which specifically targets CD64(+) cells. We show that H22(scFv)-MAP can efficiently kill proliferating HL-60 pro-monocytic cells in vitro. In addition, the human CFP specifically eliminates polarized M1 macrophages in a transgenic mouse model of cutaneous chronic inflammation. Because M1 macrophages promote the pathogenesis of many chronic inflammatory diseases, targeting this cell population with H22(scFv)-MAP could help to treat diseases such as atopic dermatitis, rheumatoid arthritis and inflammatory bowel disease.


Asunto(s)
Polaridad Celular , Macrófagos/citología , Macrófagos/metabolismo , Receptores de IgG/metabolismo , Proteínas Recombinantes de Fusión/farmacología , Proteínas tau/farmacología , Animales , Apoptosis/efectos de los fármacos , Línea Celular , Polaridad Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Células Cultivadas , Enfermedad Crónica , Humanos , Inflamación/patología , Interferón gamma/farmacología , Macrófagos/efectos de los fármacos , Ratones , Microtúbulos/efectos de los fármacos , Microtúbulos/metabolismo , Unión Proteica/efectos de los fármacos , Anticuerpos de Cadena Única/metabolismo , Piel/patología
19.
Plant Biotechnol J ; 14(12): 2203-2216, 2016 12.
Artículo en Inglés | MEDLINE | ID: mdl-27614091

RESUMEN

The CRISPR/Cas9 system and related RNA-guided endonucleases can introduce double-strand breaks (DSBs) at specific sites in the genome, allowing the generation of targeted mutations in one or more genes as well as more complex genomic rearrangements. Modifications of the canonical CRISPR/Cas9 system from Streptococcus pyogenes and the introduction of related systems from other bacteria have increased the diversity of genomic sites that can be targeted, providing greater control over the resolution of DSBs, the targeting efficiency (frequency of on-target mutations), the targeting accuracy (likelihood of off-target mutations) and the type of mutations that are induced. Although much is now known about the principles of CRISPR/Cas9 genome editing, the likelihood of different outcomes is species-dependent and there have been few comparative studies looking at the basis of such diversity. Here we critically analyse the activity of CRISPR/Cas9 and related systems in different plant species and compare the outcomes in animals and microbes to draw broad conclusions about the design principles required for effective genome editing in different organisms. These principles will be important for the commercial development of crops, farm animals, animal disease models and novel microbial strains using CRISPR/Cas9 and other genome-editing tools.


Asunto(s)
Sistemas CRISPR-Cas/genética , Endonucleasas/genética , Endonucleasas/metabolismo , Animales , Edición Génica , Humanos , Mutagénesis Sitio-Dirigida , Mutación/genética , Edición de ARN/genética
20.
Plant Biotechnol J ; 14(4): 1151-60, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26426390

RESUMEN

Genome modification by homology-directed repair (HDR) is an attractive tool for the controlled genetic manipulation of plants. Here, we report the HDR-mediated gene exchange of expression cassettes in tobacco BY-2 cells using a designed zinc finger nuclease (ZFN). The target contained a 7-kb fragment flanked by two ZFN cutting sites. That fragment was replaced with a 4-kb donor cassette, which integrates gene markers for selection (kanamycin resistance) and for scoring targeting (red fluorescent protein, RFP). Candidates resulting from cassette exchange were identified by molecular analysis of calli generated by transformation via direct DNA delivery. The precision of HDR-mediated donor integration was evaluated by Southern blot analysis, sequencing of the integration locus and analysis of RFP fluorescence by flow cytometry. Screening of 1326 kanamycin-resistant calli yielded 18 HDR events, 16 of which had a perfect cassette exchange at the insert junction and 13 of which produced functional RFP. Our results demonstrate that ZFN-based HDR can be used for high frequency, precise, targeted exchange of fragments of sizes that are commercially relevant in plants.


Asunto(s)
Desoxirribonucleasas/metabolismo , Marcación de Gen/métodos , Nicotiana/genética , Southern Blotting , Desoxirribonucleasas/genética , Citometría de Flujo/métodos , Resistencia a la Kanamicina/genética , Proteínas Luminiscentes/genética , Proteínas Luminiscentes/metabolismo , Células Vegetales , Plantas Modificadas Genéticamente , Reparación del ADN por Recombinación/genética , Nicotiana/citología , Dedos de Zinc , Proteína Fluorescente Roja
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA